Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exact Sciences

44.09
-0.0600-0.14%
Post-market: 44.110.0200+0.05%18:21 EDT
Volume:1.71M
Turnover:76.47M
Market Cap:8.19B
PE:-7.89
High:46.07
Open:45.17
Low:43.98
Close:44.15
Loading ...

Exact Sciences (EXAS) Gets a Buy from Bernstein

TIPRANKS
·
14 Jan

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market

Benzinga
·
14 Jan

Exact Sciences Price Target Maintained With a $65.00/Share by Benchmark

Dow Jones
·
13 Jan

Craig-Hallum Sticks to Their Buy Rating for Exact Sciences (EXAS)

TIPRANKS
·
13 Jan

Exact Sciences Corp - Enters Into Senior Secured Revolving Credit Agreement

THOMSON REUTERS
·
13 Jan

Exact Sciences Corp - Revolving Credit Agreement Permits Borrowings up to $500 Million

THOMSON REUTERS
·
13 Jan

Stifel Nicolaus Remains a Buy on Exact Sciences (EXAS)

TIPRANKS
·
13 Jan

Exact Sciences: Strong Q4 Results and Promising Pipeline Justify Buy Rating

TIPRANKS
·
13 Jan

Exact Sciences’ Strong Q4 Performance and Growth Prospects Justify Buy Rating

TIPRANKS
·
13 Jan

Exact Sciences Expects 10% Growth in Q4 Revenue

MT Newswires Live
·
13 Jan

Exact Sciences reports preliminary Q4 revenue $713M, consensus $694.76M

TIPRANKS
·
13 Jan

BRIEF-Exact Sciences Corp Says Full-Year 2024 Revenue Expected To Increase 10% To $2.76 Bln

Reuters
·
13 Jan

Exact Sciences Corp - Full-Year 2024 Revenue Expected to Increase 10% to $2.76 Billion

THOMSON REUTERS
·
13 Jan

Should Exact Sciences Stock Stay in Your Portfolio Right Now?

Zacks
·
08 Jan

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Inspire Medical Systems (INSP)

TIPRANKS
·
07 Jan

Exact Sciences price target raised to $70 from $60 at Evercore ISI

TIPRANKS
·
02 Jan

Exact Sciences Corporation's (NASDAQ:EXAS) Shift From Loss To Profit

Simply Wall St.
·
27 Dec 2024

Exact Sciences Is Maintained at Buy by B of A Securities

Dow Jones
·
14 Dec 2024

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

Zacks
·
13 Dec 2024

Exact Sciences Corp : Leerink Partners Raises Target Price to $95 From $70

THOMSON REUTERS
·
11 Dec 2024